CN112080478B - 一种h5亚型禽流感病毒的高效增殖方法及应用 - Google Patents
一种h5亚型禽流感病毒的高效增殖方法及应用 Download PDFInfo
- Publication number
- CN112080478B CN112080478B CN202011039170.2A CN202011039170A CN112080478B CN 112080478 B CN112080478 B CN 112080478B CN 202011039170 A CN202011039170 A CN 202011039170A CN 112080478 B CN112080478 B CN 112080478B
- Authority
- CN
- China
- Prior art keywords
- avian influenza
- influenza virus
- virus
- embryos
- subtype avian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000712461 unidentified influenza virus Species 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 39
- 241000700605 Viruses Species 0.000 claims abstract description 72
- 210000003837 chick embryo Anatomy 0.000 claims abstract description 58
- 238000004519 manufacturing process Methods 0.000 claims abstract description 34
- 239000003085 diluting agent Substances 0.000 claims abstract description 29
- 239000000243 solution Substances 0.000 claims abstract description 26
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 17
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 17
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000011592 zinc chloride Substances 0.000 claims abstract description 17
- 239000000427 antigen Substances 0.000 claims abstract description 16
- 102000036639 antigens Human genes 0.000 claims abstract description 16
- 108091007433 antigens Proteins 0.000 claims abstract description 16
- 238000001914 filtration Methods 0.000 claims abstract description 14
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 10
- 239000008055 phosphate buffer solution Substances 0.000 claims abstract description 10
- 244000052769 pathogen Species 0.000 claims abstract description 7
- 210000001161 mammalian embryo Anatomy 0.000 claims description 54
- 241000287828 Gallus gallus Species 0.000 claims description 51
- 239000007788 liquid Substances 0.000 claims description 47
- 210000002257 embryonic structure Anatomy 0.000 claims description 34
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 24
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 20
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 20
- 241001473385 H5N1 subtype Species 0.000 claims description 20
- 229940116977 epidermal growth factor Drugs 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 20
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 20
- 238000003306 harvesting Methods 0.000 claims description 16
- 238000005070 sampling Methods 0.000 claims description 15
- 229940031551 inactivated vaccine Drugs 0.000 claims description 14
- 230000002779 inactivation Effects 0.000 claims description 14
- 238000011081 inoculation Methods 0.000 claims description 14
- 238000003860 storage Methods 0.000 claims description 11
- 238000007689 inspection Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 235000013601 eggs Nutrition 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 239000011550 stock solution Substances 0.000 claims description 9
- 230000023555 blood coagulation Effects 0.000 claims description 8
- 230000000415 inactivating effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 6
- 239000008098 formaldehyde solution Substances 0.000 claims description 6
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 6
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- 239000002574 poison Substances 0.000 claims description 6
- 231100000614 poison Toxicity 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 4
- 230000003203 everyday effect Effects 0.000 claims description 4
- 230000001605 fetal effect Effects 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 230000014759 maintenance of location Effects 0.000 claims description 4
- 238000011045 prefiltration Methods 0.000 claims description 4
- 238000013207 serial dilution Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000002062 proliferating effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000003053 immunization Effects 0.000 abstract description 4
- 238000002649 immunization Methods 0.000 abstract description 4
- 102000018386 EGF Family of Proteins Human genes 0.000 abstract description 2
- 108010066486 EGF Family of Proteins Proteins 0.000 abstract description 2
- 235000005074 zinc chloride Nutrition 0.000 abstract 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract 1
- 235000013330 chicken meat Nutrition 0.000 description 39
- 238000012360 testing method Methods 0.000 description 22
- 208000002979 Influenza in Birds Diseases 0.000 description 8
- 206010064097 avian influenza Diseases 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229960003971 influenza vaccine Drugs 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 1
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 229940116978 human epidermal growth factor Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
Abstract
Description
活胚数 | 离心后HA(log2) | 离心后EID<sub>50</sub>值(10<sup>X</sup>EID<sub>50</sub>/0.1mL) | 浓缩后HA(log2) | 浓缩后EID<sub>50</sub>值(10<sup>X</sup>EID<sub>50</sub>/0.1mL) | |
试验组1 | 99 | 12 | 8.86 | / | / |
试验组2 | 98 | 12 | 8.83 | / | / |
对照组1 | 92 | 9 | 7.65 | 11 | 8.13 |
对照组2 | 93 | 9 | 7.74 | 11 | 8.19 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011039170.2A CN112080478B (zh) | 2020-09-28 | 2020-09-28 | 一种h5亚型禽流感病毒的高效增殖方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011039170.2A CN112080478B (zh) | 2020-09-28 | 2020-09-28 | 一种h5亚型禽流感病毒的高效增殖方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112080478A CN112080478A (zh) | 2020-12-15 |
CN112080478B true CN112080478B (zh) | 2021-09-21 |
Family
ID=73740042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011039170.2A Active CN112080478B (zh) | 2020-09-28 | 2020-09-28 | 一种h5亚型禽流感病毒的高效增殖方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112080478B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115960842B (zh) * | 2022-11-26 | 2023-09-01 | 哈尔滨维科生物技术有限公司 | 一种提高重组禽流感病毒感染鸡胚能力的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104212771A (zh) * | 2014-09-04 | 2014-12-17 | 天津瑞普生物技术股份有限公司 | 一种禽流感病毒增殖方法及利用该方法制备的禽流感疫苗 |
CN106754750A (zh) * | 2016-12-16 | 2017-05-31 | 青岛易邦生物工程有限公司 | 一种h5亚型禽流感病毒的增殖方法 |
CN109444409A (zh) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | 一种犬瘟热病毒抗体的化学发光免疫检测试剂盒 |
CN110841064A (zh) * | 2019-11-07 | 2020-02-28 | 衡阳师范学院 | 一种犬腺病毒ⅰ型灭活疫苗及其制备方法 |
-
2020
- 2020-09-28 CN CN202011039170.2A patent/CN112080478B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104212771A (zh) * | 2014-09-04 | 2014-12-17 | 天津瑞普生物技术股份有限公司 | 一种禽流感病毒增殖方法及利用该方法制备的禽流感疫苗 |
CN106754750A (zh) * | 2016-12-16 | 2017-05-31 | 青岛易邦生物工程有限公司 | 一种h5亚型禽流感病毒的增殖方法 |
CN109444409A (zh) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | 一种犬瘟热病毒抗体的化学发光免疫检测试剂盒 |
CN110841064A (zh) * | 2019-11-07 | 2020-02-28 | 衡阳师范学院 | 一种犬腺病毒ⅰ型灭活疫苗及其制备方法 |
Non-Patent Citations (2)
Title |
---|
Increasing the accuracy and scalability of the immunofluorescence assay for epstein barr virus by inferring continuous titers from a single sample dilution;Sherry Meow Peng Goh et al.;《J Immunol Methods》;20170131;第35-40页 * |
不同稀释液在乙型肝炎病毒DNA稀释检测中的应用研究;汪东剑等;《检验医学与临床》;20170731;第14卷(第13期);第1864-1866页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112080478A (zh) | 2020-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2172543B1 (en) | Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process | |
CN102258777B (zh) | 用鸡胚源细胞系繁殖传染性法氏囊病毒制备灭活疫苗和联苗的方法 | |
CN111000993B (zh) | 一种鸭病毒性肝炎、鸭呼肠孤病毒病二联灭活疫苗及其制备方法 | |
CN108721615B (zh) | 一种制备鸭坦布苏病毒病灭活疫苗的方法及其疫苗 | |
CN104946600B (zh) | 一种h9亚型禽流感病毒株 | |
CN103013930B (zh) | 一种鸡新城疫、传染性支气管炎病毒同胚增殖的培养方法 | |
CN110893235B (zh) | 一种鲫造血器官坏死病灭活疫苗及其制备方法 | |
CN109097340B (zh) | 一种禽腺病毒、一种四联疫苗及其制备方法 | |
CN112080478B (zh) | 一种h5亚型禽流感病毒的高效增殖方法及应用 | |
CN109207436B (zh) | 一株i群4型禽腺病毒毒株及其应用 | |
CN104689311A (zh) | 一种生产禽脑脊髓炎病毒灭活疫苗的方法 | |
WO2011134163A1 (zh) | 一种h9n2亚型禽流感灭活疫苗的制备方法及产品 | |
CN102965344B (zh) | 用细胞系生产鸡传染性支气管炎病毒与疫苗 | |
CN112143714B (zh) | 利用低免鸡胚生产h7亚型禽流感病毒灭活疫苗的方法 | |
CN111714626A (zh) | 一种采用mdck细胞系生产禽流感疫苗的方法及其制品 | |
CN112999343B (zh) | 一种鹅星状病毒的灭活疫苗及其制备方法 | |
CN106563125B (zh) | 鸭甲肝病毒ⅲ型复合物活疫苗及其制备方法 | |
CN103157107A (zh) | 用连续传代细胞系生产鸡马立克氏病疫苗及方法 | |
CN102978167A (zh) | 用细胞系生产鸡嗜肾型传染性支气管炎病毒与活疫苗 | |
CN112807424A (zh) | 牛病毒性腹泻、牛传染性鼻气管炎二联活疫苗及其制备方法 | |
CN111057683A (zh) | 一种鸡胚接种用病毒稀释液及其制备方法和应用 | |
CN109091670B (zh) | 一种禽流感病毒h9亚型二价灭活疫苗及其制备方法 | |
CN109679926B (zh) | 禽流感病毒h9亚型jxd株及应用 | |
CN115960842B (zh) | 一种提高重组禽流感病毒感染鸡胚能力的方法 | |
CN113073084A (zh) | 提高鸡传染性支气管炎病毒增殖的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A highly efficient method for proliferation of H5 subtype avian influenza virus and its application Effective date of registration: 20221020 Granted publication date: 20210921 Pledgee: Agricultural Bank of China Limited Guangzhou Development Zone Branch Pledgor: GUANGDONG WINSUN BIOPHARMACEUTICALS CO.,LTD. Registration number: Y2022980014976 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231123 Granted publication date: 20210921 Pledgee: Agricultural Bank of China Limited Guangzhou Development Zone Branch Pledgor: GUANGDONG WINSUN BIOPHARMACEUTICALS CO.,LTD. Registration number: Y2022980014976 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: An efficient proliferation method and application of H5 subtype avian influenza virus Effective date of registration: 20231206 Granted publication date: 20210921 Pledgee: Agricultural Bank of China Limited Guangzhou Development Zone Branch Pledgor: GUANGDONG WINSUN BIOPHARMACEUTICALS CO.,LTD. Registration number: Y2023980069708 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |